Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules

Int J Mol Sci. 2020 Apr 22;21(8):2934. doi: 10.3390/ijms21082934.

Abstract

Cutaneous melanoma (CM) is an aggressive type of skin cancer for which effective biomarkers are still needed. Recently, the protein content of extracellular vesicles (ectosomes and exosomes) became increasingly investigated in terms of its functional role in CM and as a source of novel biomarkers; however, the data concerning the proteome of CM-derived ectosomes is very limited. We used the shotgun nanoLC-MS/MS approach to the profile protein content of ectosomes from primary (WM115, WM793) and metastatic (WM266-4, WM1205Lu) CM cell lines. Additionally, the effect exerted by CM ectosomes on recipient cells was assessed in terms of cell proliferation (Alamar Blue assay) and migratory properties (wound healing assay). All cell lines secreted heterogeneous populations of ectosomes enriched in the common set of proteins. A total of 1507 unique proteins were identified, with many of them involved in cancer cell proliferation, migration, escape from apoptosis, epithelial-mesenchymal transition and angiogenesis. Isolated ectosomes increased proliferation and motility of recipient cells, likely due to the ectosomal transfer of different cancer-promoting molecules. Taken together, these results confirm the significant role of ectosomes in several biological processes leading to CM development and progression, and might be used as a starting point for further studies exploring their diagnostic and prognostic potential.

Keywords: biomarkers; cutaneous melanoma; ectosomes; extracellular vesicles; invasion; metastasis; proteomics.

MeSH terms

  • Biomarkers
  • Cell Line, Tumor
  • Cell-Derived Microparticles / metabolism*
  • Chromatography, Liquid
  • Computational Biology / methods
  • Exosomes / metabolism*
  • Gene Expression Profiling
  • Gene Ontology
  • Humans
  • Melanoma / genetics
  • Melanoma / metabolism*
  • Melanoma, Cutaneous Malignant
  • Proteomics*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / metabolism*
  • Tandem Mass Spectrometry*

Substances

  • Biomarkers